Pro Medicus Ltd
ASX:PME

Watchlist Manager
Pro Medicus Ltd Logo
Pro Medicus Ltd
ASX:PME
Watchlist
Price: 249.99 AUD -0.73% Market Closed
Market Cap: 26.1B AUD

Pro Medicus Ltd
Investor Relations

Pro Medicus Ltd, an Australian company founded in 1983, has etched its name in the field of healthcare IT, primarily through its innovative medical imaging software solutions. The brainchild of Dr. Sam Hupert and Anthony Hall, the company originally sought to provide radiology practices with digital solutions for image management and viewing. Over the years, Pro Medicus has meticulously evolved its offerings to become a leader in picture archiving and communication systems (PACS), radiology information systems (RIS), and an expanding range of e-health solutions. Its flagship product, Visage 7, is renowned for delivering fast and sophisticated viewing capabilities, enabling radiologists to efficiently interpret complex imaging data. Under its hood, the company’s technology is powered by advanced streaming capabilities, allowing for large files to be quickly accessed and reviewed, essential for high-demand environments.

The monetization model of Pro Medicus largely revolves around licensing agreements for its software, alongside service and support fees, ensuring a steady and recurring revenue stream. The company has successfully leveraged its expertise to penetrate key markets, notably the United States and Europe, where it partners with some of the most prestigious hospitals and research institutions. By focusing on high-end offerings and fostering long-term client relationships, Pro Medicus has cemented a premium positioning in the healthcare IT landscape. The strategic focus on innovation, coupled with a keen understanding of the evolving needs of healthcare providers, allows Pro Medicus to continually refine its services, ensuring it remains at the forefront of technological advancements that ultimately enhance diagnostic efficiency and patient outcomes.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q4 2023
Call Date
Aug 14, 2023
AI Summary
Q4 2023

Record Year: Pro Medicus posted its most successful year ever, with revenue, profit, and cash reserves all growing significantly.

Revenue Growth: Transaction revenue rose by over 44%, driven by seven new North American contracts and a major renewal with the University of Florida.

Margin Expansion: EBIT margins improved from 66% to over 67%, despite increased headcount and investment.

Cloud Adoption: All implementations in the past year were cloud-based, and management sees this as a strategic advantage over competitors.

Strong Pipeline: The company reports a robust pipeline across multiple market segments and expects continued growth.

AI & Cardiology: First commercial contracts for cardiology and AI products are expected within six months.

Implementation Efficiency: Eight cloud implementations were completed during the year, with processes becoming faster and more scalable.

Recurring Revenue: The firm emphasizes the predictability and growth of recurring transaction and service contract revenues.

Key Financials
Cash Reserves
Over $120 million
Dividend per Share
$0.17 per share fully franked
EBIT Margin
67%
Minimum Contracted Revenue (US Operations)
$468 million over five years
University of Florida Contract
$15.5 million over 7 years
Gundersen Contract
$20 million over 7 years
Earnings Call Recording
Other Earnings Calls
2022

Management

Dr. Sam Aaron Hupert M.B.B.S., M.D.
Co-Founder, CEO, MD & Executive Director
No Bio Available
Mr. Anthony Barry Hall B.Sc., B.Sc.(Hons), M.Sc.
Co-Founder, Technology Director & Executive Director
No Bio Available
Mr. Clayton James Hatch B.Comm, CPA, CPA
Chief Financial Officer
No Bio Available
Dr. Malte Westerhoff
GM of Europe & Global CTO
No Bio Available
Mr. Brad Levin
GM of North America & Global Head of Marketing
No Bio Available
Ms. Sharni L. Redenbach
People & Culture Director
No Bio Available
Mr. Sean Lambright
Global Head of Sales - Visage Imaging Inc
No Bio Available
Ms. Teresa Gschwind
Global Head of Customer Service of Visage Imaging Inc.
No Bio Available
Ms. Danny English C.A.
Financial Controller & Company Secretary
No Bio Available

Contacts

Address
VICTORIA
RICHMOND
Richmond, 450 Swan St
Contacts
+61394298800.0
www.promed.com.au